The association between Cytomegalovirus co-infection with Pneumocystis pneumonia and mortality in immunocompromised non-HIV patients.
Pervin Korkmaz EkrenZehra Nur ToreyinPayam NahidMert DoskayaAyse CanerNevin TurgayAysin ZeytinogluSeray TozFeza BacakogluYuksel GuruzSelda ErensoyPublished in: The clinical respiratory journal (2019)
The risk of mortality appears to be increased in the setting of CMV and PCP co-infection in HIV-uninfected immunocompromised patients. PCP prophylaxis use was lower than expected, suggesting low physician awareness of the risks of PCP in this population.
Keyphrases
- end stage renal disease
- hiv infected
- ejection fraction
- chronic kidney disease
- newly diagnosed
- antiretroviral therapy
- emergency department
- human immunodeficiency virus
- hepatitis c virus
- prognostic factors
- hiv positive
- primary care
- peritoneal dialysis
- cardiovascular disease
- cardiovascular events
- type diabetes
- patient reported outcomes
- intensive care unit
- climate change
- acute respiratory distress syndrome
- extracorporeal membrane oxygenation
- patient reported